Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters
Database
Language
Publication year range
1.
Pembrolizumab-associated chronic rhinosinusitis: A new endotype and management considerations.
Standiford, Taylor C; Patel, Neil N; Singh, Amritpal; Gochman, Grant; Jamie Wu, Tara; Daud, Adil I; Goldberg, Andrew N.
Int Forum Allergy Rhinol ; 13(12): 2248-2251, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37317899

ABSTRACT

KEY POINTS: Patients treated with pembrolizumab experience an increase in paranasal sinus inflammation Use of topical triamcinolone in carboxymethylcellulose is a treatment option for such patients.


Subject(s)
Paranasal Sinuses , Rhinitis , Sinusitis , Humans , Rhinitis/drug therapy , Sinusitis/drug therapy , Chronic Disease
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL